Nicholas Lydon
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.
Affilié au moment de l'attribution du prix
Basel, Suisse
La reconnaissance d'un travail ayant un impact durable
For the development of molecularly-targeted treatments for chronic myeloid leukemia, converting a fatal cancer into a manageable chronic condition.
Basel, Suisse